论文部分内容阅读
1995年10月～1997年9月本院将118例孕16～26周需终止妊娠的健康妇女，随机分成米非司酮配伍米索前列醇组及利凡诺组，进行临床对比，现将结果报告如下。临床资料一、对象选择及分组118例孕16～26周要求终止妊娠的健康妇女，无生殖道畸形，经妇科检查或B超确诊后随机分为A、B两
From October 1995 to September 1997, 118 healthy women who needed termination of pregnancy during 16-26 weeks of gestation were randomly divided into mifepristone group and misoprostol group and rivanol group. The results are reported below. Clinical data First, the object selection and group 118 cases of pregnancy 16 to 26 weeks required termination of pregnancy in healthy women, no genital tract deformity, gynecological examination or B-diagnosed randomly divided into A, B two